medigraphic.com
ISSN 1028-9933 (Electronic)

2022, Number 6

<< Back Next >>

RIC 2022; 101 (6)

Update notes on neurocysticercosis

López-Barrionuevo CG, Salazar-Pullutacsi KD, Villacis-Paredes GA

Language: Spanish
References: 20
Page: 1-15
PDF size: 420.49 Kb.


ABSTRACT

Introduction: Neurocysticercosis is a preventable parasitic infection caused by larval cysts of Taenia solium (tapeworm), which can infect any part of the body, including the brain and is the most severe form of the disease, sometimes lead to seizures and even be fatal.
Objective: To synthesize information concerning this pathology.
Method: An updated bibliographic search was carried out in databases such as PubMed, Google Scholar, Medline, Web of Science, Cochrane Library and ClinicalKey, as well as in high impact journals like SciELO, and Scopus. The information gathered was complemented with the use of systematic reviews, randomized clinical studies and meta-analysis approaches, in which to facilitate the search process various key words were used: "neurocysticercosis", "pathophysiology", "etiology", "clinical manifestations", "prevalence", "morbimortality", "diagnosis", and "treatment".
Development: The research allowed the researchers to recognize the arduous work required for the diagnosis of this disease, assuming as well how difficult is to typify it. The importance of neuroimaging studies as tools to qualify the severity of neurocysticercosis and, thus, to choose the appropriate treatment was highlighted. The following sections were developed: epidemiology, etiopathogenesis, life cycle, clinical manifestations, classification, and evolution of lesions, diagnosis, diagnostic criteria, and treatment.
Conclusions: Ecuador is considered an endemic country for Taeniasolium. The implementation of preventive actions should be regarded as a fundamental task of the Ministry of Health due to the permanent surrounding risk factors, which have an influence for getting infection and the set of aspects associated with the precarious quality of life in many parts of the country.


REFERENCES

  1. Veeravigrom M, Thampratankul L. Neurocysticercosis in Children. Ped Clin North Am [Internet]. 2022 Feb [citado 28/09/2022]; 69(1):115-27. Disponible en: https://doi.org/10.1016/j.pcl.2021.09.0051.

  2. Soto-Cossio E, Vicente-Hernández B, Pacheco G, Méndez-Rosito D. Neurocisticercosis ventricular: manejo multimodal y revisión de la bibliografía. Med Int Mex [Internet]. 2018 Dic [citado 28/09/2022]; 34(5):797-803. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=838302.

  3. Campos Duarte K, Vargas Mena R, Hidalgo Azofeifa SH. Neurocisticercosis. Rev Med Sinergia [Internet]. 2021 Nov [citado 26/09/2022]; 6(11):e729-e729. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/7293.

  4. Lafuente González AP, Roldán Pinargote FE, Soto Silva GA, Arias Carvajal SM. Neurocisticercosis, diagnóstico y tratamiento. RECIMUNDO [Internet]. 2022 Jul [citado 10/10/2022]; 6(3):136-46. Disponible en: https://www.recimundo.com/index.php/es/article/view/16844.

  5. White AC, Coyle CM, Rajshekhar V, Singh G, Hauser WA, Mohanty A, et al. Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Inf Dis [Internet]. 2018 Abr [citado 18/10/2022]; 66(8):e49-75. DOI: https://doi.org/10.1093/cid/cix10845.

  6. Garcia HH. Neurocysticercosis. Neurol Clin [Internet]. 2018 Nov [citado 28/09/2022]; 36(4):851-64. Disponible en: https://doi.org/10.1016/j.ncl.2018.07.0036.

  7. WHO. Teniasis y cisticercosis. www.who.int. [citado 28/09/2022]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/taeniasis-cysticercosis7.

  8. Naranjo Aulestia KM, Cordovilla Gavilanes LW, Gómez Leyva B. Neurocisticercosis quística [Internet]. Riobamba, Ecuador: Escuela Superior Politécnica de Chimborazo; 2019. [citado 27/09/2022]. Disponible en: http://biblioteca.espoch.edu.ec/cgi-bin/koha/opac-detail.pl?biblionumber=676458.

  9. Perez A, Syngal G, Fathima S, Laali S, Shamim S. Intraventricular neurocysticercosis causing obstructing hydrocephalus. Proc (Bayl Univ Med Cent) [Internet]. 2022 [citado 28/09/2022]; 35(5):722-4. DOI: https://doi.org/10.1080/08998280.2022.20756699.

  10. Centers for Disease Control and Prevention. Parasites-Cysticercosis. Biology. Life Cycle. www.cdc.gov. 2022 [citado 27/09/2022]. Disponible en: https://www.cdc.gov/parasites/cysticercosis/biology.html10.

  11. Small J, Noujaim D, Ginat D, Kelly H, Schaefer P. Neuroradiology: Spectrum and Evolution of Disease. 1ed [Internet]. Elsevier; 2018. [citado 27/08/2022]. Disponible en: https://www.elsevier.com/books/neuroradiology-spectrum-and-evolution-of-disease/small/978-0-323-44549-811.

  12. Urbina Sempertegui S. "Características clínico-epidemiológicas e imagenológicas de pacientes con diagnóstico de neurocisticercosis atendidos en el Hospital Regional Docente de Cajamarca durante el año 2019". [Tesis Médico Cirujano]. Perú: Universidad Nacional de Cajamarca; 2022 [citado 28/09/2022]; Disponible en: http://repositorio.unc.edu.pe/handle/20.500.14074/485212.

  13. Castro Alonzo KJ, Sabando Farías CI. Inmunopatogenesis, diagnóstico y perfil clínico de la neurocisticercosis [Thesis Laboratorio Clínico]. Jipijapa: UNESUM; 2021 [citado 27/09/2022]. Disponible en: http://repositorio.unesum.edu.ec/handle/53000/314513.

  14. Coyle CM. Neurocysticerosis: An Individualized Approach. Infect Dis Clin North Am [Internet]. 2019 Mar [citado 28/09/2022]; 33(1):153-68. Disponible en: https://doi.org/10.1016/j.idc.2018.10.00714.

  15. Gutiérrez MAR, Cárdenas SB, Páez AMR, Rodríguez LJV. Neurocisticercosis: Caso clínico. Ciencia e Innovación en Salud [Internet]. 2020 sep. [citado 19/09/2022]; Disponible en: https://revistas.unisimon.edu.co/index.php/innovacionsalud/article/view/393715.

  16. Guzman C, Garcia HH. Cysticercosis Working Group in Peru. Current Diagnostic Criteria for Neurocysticercosis. Res Rep Trop Med [Internet]. 2021 [citado 22/09/2022]; 12:197-203. DOI: https://doi.org/10.2147/rrtm.s28539316.

  17. White AC, Weller PF. Infecciones por cestodos. En: Araiza Martínez ME, Blengio Pinto JR, Pérez Tamayo AM, Lira Albarrán S, Barrera Villavicencio H, Talamás Rhoana P. Harrison. Principios de Medicina Interna. 19ed [Internet]. McGraw Hill Medical; 2016. [citado 26/09/2022]. Disponible en: https://accessmedicina.mhmedical.com/content.aspx?bookid=1717§ionid=11492634717.

  18. Ruiz Acosta R. La Neurocisticercosis: enfermedad parasitaria olvidada, desatendida, y emergente. www.cienciamayabeque2021. 2021 [citado 27/09/2022]; Disponible en: http://www.cienciamayabeque2021.sld.cu/index.php/Fcvcm/Cienciamayabeque2021/paper/view/20418.

  19. Garcia HH, O'Neal SE, Noh J, Handali S. Laboratory Diagnosis of Neurocysticercosis (Taenia solium). J Clin Microbiol [Internet]. 2018 Sep [citado 28/09/2022]; 56(9):e00424-18. Disponible en: https://doi.org/10.1128/jcm.00424-1819.

  20. Osborn A, Digre K. Imaging in Neurology. 1ed [Internet]. Elsevier; 2016. [citado 23/09/2022]. Disponible en: https://www.elsevier.com/books/imaging-in-neurology/978-0-323-44781-220.




2020     |     www.medigraphic.com